NCT06717139View on ClinicalTrials.gov

Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD

Active, not recruitingOBSERVATIONAL

Enrollment

220

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

May 9, 2026

Study Completion Date

May 9, 2027

Conditions

Retinal DiseasesMacular DegenerationNeovascular (Wet) Age-Related Macular Degeneration

Trial Locations (1)

17164

St Erik Eye Hospital, Stockholm

All Listed Sponsors

lead

St. Erik Eye Hospital

OTHER